Foamix Pharmaceuticals Ltd. Research and Development in Process
Foamix Pharmaceuticals Ltd. reported Research and Development in Process of $5.62 million for the 12-month period ending 2015-12-31, per its 20-F filed 2016-03-02.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2016-03-02
| Period end | Research and Development in Process 12 month |
|---|---|
| 2015-12-31 | $5.62M 20-F · filed 2016-03-02 |
| 2014-12-31 | $1.58M 20-F · filed 2016-03-02 |
| 2013-12-31 | $73.00K 20-F · filed 2016-03-02 |
| 2012-12-31 | $110.00K 20-F · filed 2015-03-17 |